Tag: cambrex

January 2, 2019

Cambrex Completes Acquisition of Avista Pharma Solutions

Cambrex (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, today...
February 8, 2018

Cambrex Reports Fourth Quarter and Full Year 2017 Financial Results

Cambrex (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reports results for the fourth quarter...
January 30, 2018

Cambrex Expands Process Research and Development Capabilities Across North America

Cambrex (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced an investment to...
October 3, 2016

Cambrex Opens New Pilot Plant at Its Milan, Italy Site

Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, today announced the validation and ISO...
March 1, 2016

Provectus Biopharmaceuticals Awarded Patent Extending Protection of the PV-10 Manufacturing Process

Provectus Biopharmaceuticals, Inc. (NYSEMKT:PVCT) announced that it has received a patent from the US Patent and Trademark Office, US Patent...